⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001866197

Ashton-Rickardt Philip

Reports to the SEC for 1 company · CAMBRIDGE, MA

Transactions

5

Companies

1

Filings

5

CIK

0001866197

Forms 4 and 5

Insider transactions

5 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-08-11	Sigilon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	CHIEF SCIENTIFIC OFFICER	DDisposition to Issuer	−8,845 sh	$0.75	−$6,633.75	0
2023-02-28	Sigilon Therapeutics, Inc.Stock Option (Right to Buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+115K sh	—	—	115,000
2022-02-18	Sigilon Therapeutics, Inc.Stock Option (Right to Buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+90K sh	$1.48	+$133K	90,000
2022-01-03	Sigilon Therapeutics, Inc.Stock Option (Right to Buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+90K sh	$3.03	+$273K	90,000
2021-07-01	Sigilon Therapeutics, Inc.Stock Option (Right to Buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+90K sh	—	—	90,000

Recent filings

5

Accepted (ET)
Aug 114
Ashton-Rickardt Philip0001415889-23-012129
SEC(opens sec.gov)
Mar 14
Ashton-Rickardt Philip0001415889-23-003675
SEC(opens sec.gov)
Feb 224
Ashton-Rickardt Philip0001415889-22-001635
SEC(opens sec.gov)
Jan 44
Ashton-Rickardt Philip0001415889-22-000195
SEC(opens sec.gov)
Jul 24
Ashton-Rickardt Philip0001415889-21-003390
SEC(opens sec.gov)

Companies

1

Sigilon Therapeutics, Inc.CHIEF SCIENTIFIC OFFICER

Address

C/O SIGILON THERAPEUTICS, INC. 100 BINNEY STREET STE 600

CAMBRIDGE, MA, 02142